Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 1; peer review: awaiting peer review]
Schweiger, LMSW, Abigail, Diniz, MD, PhD, Breno, Nicol, MD, CEDS, Ginger, Schweiger, Julie, Dasklakis-Perez, BA, Andes, Lenze, MD, Eric J
Published in F1000 research (2024)
Published in F1000 research (2024)
Get full text
Journal Article